AzTrials
AzTrials

Corneal EctasiaEyeTwinNCT04475900

Computer-aided Diagnosis of Ocular Diseases Based on Corneal Biomechanics

An observational study of Corneal Ectasia and Corneal Disease, run by Technische Universität Dresden at 1 site in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is the investigation of biomechanical properties of the cornea using computer-aided data analysis. Currently, it is known that keratoconus and glaucoma are ocular disease that are associated with biomechanical alterations of the cornea. Read more about this study

Who is it for?
Ages 18 to 99 yearsHealthy volunteers can take part
What is being tested?
Corneal biomechanics (Corvis ST, Oculus, Wetzlar, Germany), Corneal topography and tomography (Pentacam, Oculus, Wetzlar, Germany) and Optic nerve head measurement
How many people
372 participants
Where
1 siteGermany
Study dates
9 Jul 2020to 31 Jul 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 99 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Patients with corneal ectasia or glaucoma. Healthy eyes that matching to ocular disease groups concerning age.

Who may be able to join

  • corneal ectasia (keratoconus) or ectasia suspect
  • glaucoma (Primary open angle glaucoma and normal Tension glaucoma) or glaucoma suspect

Who cannot join

  • age under 18 years
  • pregnancy

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • Department of Ophthalmology; Medical Faculty Carl Gustav Carus; Technical University Dresden

    Dresden, Saxony, 01307

Other trials in Germany

About this study

Official title: Computer-aided Diagnosis of Ocular Diseases Based on Corneal Biomechanics - Selection and Evaluation of Eligible Patients With Certain Ocular Diseases Associated With Biomechanical Alterations

The purpose of this study is the investigation of biomechanical properties of the cornea using computer-aided data analysis. Currently, it is known that keratoconus and glaucoma are ocular disease that are associated with biomechanical alterations of the cornea. Corneal ectasia, especially keratoconus, is a corneal disease that leads to an irreversible loss of visual acuity while the cornea becomes steeper, thinner and irregular. For these patients, surgical intervention (e.g. corneal cross-linking) is performed, in case of disease progression. In glaucoma, the information about corneal alterations serves in two ways, first, correct measurement of intra ocular pressure (IOP); second, early diagnosis of suspects before visual field defects are detectable.

Especially, the Corvis ST is an air-puff tonometer that measures intraocular pressure, corneal thickness (CCT) as well as dynamic corneal response (DCR) parameters. Most of the DCR parameters are affected by IOP and CCT: Therefore, algorithm are needed to determine parameters without impact of IOP and CCT that are describe the biomechanical properties of the cornea.

Read the detailed description

In this study, an eye twin based on finite element modeling is used to measure advanced properties of corneal biomechanics. Raw data of Corvis ST measurement are exported from the device and imported into the model. The outcome of these calculations are merged together and are compared to further clinical findings (e. g. corneal topography and tomography, axial eye length).

Further information were obtained:

Age, sex, refraction, family history, known duration of disease, previous ocular surgery, systemic diseases, systemic and topical medication; biomicroscopy, anterior optical coherence tomography (OCT), Scheimpflug-based tomography (Pentacam), Biomechanical assessment (Ocular Response Analyzer and Corneal Visualization with the Scheimpflug Technology), optical biometry, confocal microscopy, endothelium cell count.

Being tested
Corneal biomechanics (Corvis ST, Oculus, Wetzlar, Germany), Corneal topography and tomography (Pentacam, Oculus, Wetzlar, Germany), Optic nerve head measurement
Keywords
Cornea, Ectasia, Keratoconus, Finite Element Modelling, computer-aided data analysis, Glaucoma, Corneal biomechanics
Medical subject headings
Corneal Diseases, Astigmatism, Keratoconus, Glaucoma, Glaucoma, Open-Angle, Low Tension Glaucoma, Dilatation, Pathologic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Corneal biomechanics (Corvis ST, Oculus, Wetzlar, Germany)Diagnostic test

    To measure corneal biomechanics with Scheimpflug based tonometry

  • Corneal topography and tomography (Pentacam, Oculus, Wetzlar, Germany)Diagnostic test

    To measure corneal topography and tomography with Scheimpflug tomograph

  • Optic nerve head measurementDiagnostic test

    To measure optic nerve excavation

Study groups in NCT04475900
Study groupRoleWhat they receive
HealthyHealthy eyes without any signs of ocular diseases
Receives: Diagnostic Test: Corneal biomechanics (Corvis ST, Oculus, Wetzlar, Germany); Diagnostic Test: Corneal topography and tomography (Pentacam, Oculus, Wetzlar, Germany); Diagnostic Test: Optic nerve head measurement
Ectasiaectasia suspects early, moderate and advanced keratoconus
Receives: Diagnostic Test: Corneal biomechanics (Corvis ST, Oculus, Wetzlar, Germany); Diagnostic Test: Corneal topography and tomography (Pentacam, Oculus, Wetzlar, Germany)
GlaucomaNormal Tension glaucoma Primary Open-Angle Glaucoma
Receives: Diagnostic Test: Corneal biomechanics (Corvis ST, Oculus, Wetzlar, Germany); Diagnostic Test: Corneal topography and tomography (Pentacam, Oculus, Wetzlar, Germany); Diagnostic Test: Optic nerve head measurement

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. New biomechanical parameters of the cornea

    To detemine biomechanical alterations in different ocular diseases and correlate them with other clinical findings

    Measured: 2 years

Secondary outcomes (1)
  1. Dependence of new biomechanical Parameters of the cornea from influencing factors

    1. g. corneal thickness, intraocular pressure

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Jul 2020
  2. Study start9 Jul 2020
  3. Primary completion30 Apr 2022
  4. Study completion31 Jul 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
372 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04475900
Sponsor's protocol ID
BO-EK-195052020
Acronym
EyeTwin
Status last verified
Aug 2022
First submitted
14 Jul 2020
Last updated
11 Aug 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes

Questions about this trial

What is this clinical trial studying?

An observational study of Corneal Ectasia and Corneal Disease, run by Technische Universität Dresden at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Aug 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

New biomechanical parameters of the cornea (time frame: 2 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Aug 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in